ARCA Biopharma Inc

Type: Company
Name: ARCA Biopharma Inc
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Arca Biopharma (ABIO) Announces Quarterly Results

Arca Biopharma (NASDAQ:ABIO) announced its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.13) by $0.02, AmericanBankingNews.com reports. Arca Biopharma (NASDAQ:ABIO) ... [Published American Banking News - Forex - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 4 reports

ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application

Canadian Site Activation for Phase 2B/3 Clinical Trial to Begin in2014Related Biotechnology, Pharmaceutical and Healthcare NewsGencaro Potentially the First Genetically-Targeted Cardiovascular TreatmentARCA biopharma , Inc. (Nasdaq: ABIO), a biopharmaceutical ... [Published BioPortfolio - Aug 18 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Biotech Stock Directory Update

(Investorideas.com Newswire) Investorideas.com staff: Investorideas.com, a global news source covering leading sectors issues the updated biotech stock directory for August.The directory is part of the member's directory list including tech and water ... [Published InvestorIdeas.com - Aug 14 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

ARCA Biopharma has the Lowest Sales per Share in the Biotechnology Industry (ABIO, AVXL, GALT, GTXI, INFI)

(Comtex SmarTrend(R)) Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.ARCA Biopharma ranks lowest with a ... [Published Individual.com - Aug 14 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Potential Blockbuster Drug Could Move ARCA's Share Price Higher

0 comments Jul 29, 2014 1:39 PM| about stocks: ABIO , MDT , MRK , BMY(click to enlarge) ARCA Biopharma (NASDAQ: ABIO ), a company focused on producing genetically-targeted remedies for cardiovascular diseases, disclosed that the first patient has already ... [Published Seeking Alpha - Jul 29 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

5 Stocks Under $10 Set to Soar

 Delafield, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline ... [Published The Street Latest - May 29 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

ARCA biopharma to Present at the Growth Capital Expo 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ... [Published Business Wire Health News - Apr 22 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 3 reports

ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

ARCA biopharma Files Shelf Registration Statement

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with ... [Published Business Wire Health News - Apr 04 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba ... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Entities: ARCA Biopharma Inc
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Small-Cap Biotech on the Verge of a Breakout: ABIO

DELAFIELD, Wis. (Stockpickr) -- Small-cap biotech stocks are all the rage on Wall Street right now. >>5 Stocks With Big Insider BuyingJust take a look at shares of Oxigene , which are ripping higher today by close to 100% after the company reported ... [Published The Street Latest - Mar 12 2014]

More Content

All (21) | News (7) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Arca Biopharma (ABIO) Announces Quarterly Results [Published American Banking News - Forex - Aug 19 2014]
ARCA biopharma Announces Health Canada Acceptan... [Published BioPortfolio - Aug 18 2014]
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire Photo/Multimedia News - Aug 18 2014]
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire Health News - Aug 18 2014]
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire News with Multimedia - Aug 18 2014]
Biotech Stock Directory Update [Published InvestorIdeas.com - Aug 14 2014]
ARCA Biopharma has the Lowest Sales per Share i... [Published Individual.com - Aug 14 2014]
Potential Blockbuster Drug Could Move ARCA's Sh... [Published Seeking Alpha - Jul 29 2014]
5 Stocks Under $10 Set to Soar [Published The Street Latest - May 29 2014]
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Health News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire News with Multimedia - Apr 17 2014]
ARCA biopharma Files Shelf Registration Statement [Published Business Wire Health News - Apr 04 2014]
ARCA biopharma CEO Michael R. Bristow to Be Int... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Small-Cap Biotech on the Verge of a Breakout: ABIO [Published The Street Latest - Mar 12 2014]
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
ARCA adds to board of directors [Published PE Hub Blog - Feb 12 2014]
Dan Mitchell Joins ARCA biopharma Board of Dire... [Published Business Wire Health News - Feb 12 2014]
ARCA biopharma Announces Pricing of $9 Million ... [Published Business Wire Health News - Feb 04 2014]
ARCA biopharma Announces Proposed Public Offeri... [Published Business Wire Health News - Feb 03 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire Photo/Multimedia News - Aug 18 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces Health Canada acceptance of GENETIC-AF clinical trial application. Canadian site activation for atrial fibrillation clinical trial to begin in 2014. ...
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire Health News - Aug 18 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces Health Canada acceptance of GENETIC-AF clinical trial application. Canadian site activation for atrial fibrillation clinical trial to begin in 2014. ...
ARCA biopharma Announces Health Canada Acceptan... [Published Business Wire News with Multimedia - Aug 18 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces Health Canada acceptance of GENETIC-AF clinical trial application. Canadian site activation for atrial fibrillation clinical trial to begin in 2014. ...
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
1 2 3

Press Releases

sort by: Date | Relevance
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.